Emerging Concepts in the Management and Treatment of Osteonecrosis of the Jaw
Publication Date
2013
Journal Title
Oral Maxillofac Surg Clin North Am
Abstract
Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2004, there have been multiple retrospective, prospective, and case-control studies that have served to characterize the diagnosis, associated risk factors, and treatment of this new complication. Bisphosphonate-related osteonecrosis of the jaw is at present associated with several risk factors that are identified across several disciplines in medicine and dentistry. With this level of broad-based recognition, new clinical and basic science research initiatives have begun and are likely to elucidate the etiopathogenesis of this disease process, significantly improving the level of disease management and prevention. © 2013 Elsevier Inc.
Volume Number
25
Issue Number
1
Pages
11 - 20
Document Type
Article
Status
Faculty
Facility
School of Medicine
Primary Department
Dental Medicine
PMID
DOI
10.1016/j.coms.2012.10.002